Nevertheless, most patients classified as demyelinating or equivocal in the current study also exhibited high serum NfL in the first 2 weeks indicating that to some extent axonal involvement occurs in most—if not all—patients with GBS. This evidence concerns the gene NEFL and Guillain-Barre syndrome.